![]() Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. | Medicalsystem Biotechnology Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider. | ![]() MorphoSys MorphoSys is a biotechnology company focused on the research and development of fully human antibodies. | ||
Founding Date | Founding Date 2005 | Founding Date 2007 | Founding Date 2003 | Founding Date 1992 |
Type | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Berlin, DE HQ | Locations Miami, US HQ Woburn, US | Locations Ningbo Shi, CN HQ | Locations Planegg, DE HQ Boston, US |
Employees | Employees 353% decrease | Employees 6,0967% increase | Employees 2,104 | Employees 464 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) 578.8 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $606.9m (FY, 2025) | Revenue (est.) ¥1.5b (FY, 2025) | Revenue (est.) €238.3m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $400.9m (FY, 2025) | Cost of goods ¥972.7m (FY, 2025) | Cost of goods €34.6m (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit $205.9m (FY, 2025) | Gross profit ¥547.3m (FY, 2025) | Gross profit €205.5m (FY, 2023) |
Net income | Net income N/A | Net income ($225.7m) (FY, 2025) | Net income ¥61.4m (FY, 2025) | Net income (€189.7m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 31m | Total funding raised N/A | Total funding raised $ 126m |

Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
View companyMedicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider.
View company
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
View company